Abstract
The use of a compound of formula (Ia): wherein A and B are independently selected from a cyclic ring, wherein each of which cyclic rings A and B may be optionally substituted at least one ring position; and L is a suitable linker; or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting ADP-ribosyl cyclase.
| Original language | English |
|---|---|
| Patent number | WO02098397A3 |
| IPC | A61K31/7084,A61P37/00 |
| Priority date | 7/06/01 |
| Filing date | 6/06/02 |
| Publication status | Published - 12 Dec 2002 |
Fingerprint
Dive into the research topics of 'Therapeutic compositions for modulating the immune response in a mammal and use thereof'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS